The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 03, 2019

Filed:

Feb. 23, 2016
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Marjan Huizing, Santa Cruz, CA (US);

May C. Malicdan, Rockville, MD (US);

Nuria Carrillo, Bethesda, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7008 (2006.01); A61K 31/7012 (2006.01); A61K 31/702 (2006.01); A61P 9/00 (2006.01); A61K 45/06 (2006.01); A61K 31/7088 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 9/50 (2006.01); A61K 47/20 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7008 (2013.01); A61K 9/0053 (2013.01); A61K 9/127 (2013.01); A61K 9/50 (2013.01); A61K 31/702 (2013.01); A61K 31/7012 (2013.01); A61K 31/7088 (2013.01); A61K 45/06 (2013.01); A61K 47/20 (2013.01); A61P 9/00 (2018.01);
Abstract

Methods are disclosed for treating a subject with a vascular or cardiac disorder associated with oxidative stress. Methods are disclosed for treating a subject with GNE myopathy that has impaired cardiac function. These methods include administering to the subject a therapeutically effective amount of a acid, or one or more sialylated compounds, mannosamine, N-acetyl mannosamine or a derivative thereof. In other embodiments, methods are disclosed for detecting a disorder associated with oxidative stress.


Find Patent Forward Citations

Loading…